Clinical Trials Browser

Phase NA × Hematologic Diseases × Alemtuzumab × Clear all

NCT00582894 2011-04-22

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

Phase NA Completed

17 enrolled 9 charts

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms